Venetoclax versus bortezomib, in combination with daratumumab and dexamethasone, in patients with t(11;14)-positive relapsed or refractory multiple myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
multiple myeloma,bortezomib,daratumumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要